Spark Therapeutics' Series B Round

Spark Therapeutics raised a round of funding on May 27, 2014.

Spark Therapeutics is developing curative, one-time gene therapy products with the potential to transform the lives of patients and re-imagine the treatment of debilitating diseases. Spark's lead gene…

Articles about Spark Therapeutics' Series B Round: